News
NAKAW
0.202
NaN%
--
Weekly Report: what happened at NAKA last week (0831-0904)?
Weekly Report · 9h ago
Crypto Currents: Coinbase files for SEC approval to offer equity perpetuals
TipRanks · 3d ago
Nakamoto Is Maintained at Buy by B. Riley Securities
Dow Jones · 4d ago
Nakamoto Price Target Raised to $11.00/Share From $9.00 by B. Riley Securities
Dow Jones · 4d ago
Can Bitcoin Treasury Firms Become the Next Berkshire Hathaway?
Benzinga · 4d ago
Trump's Crypto Ally Fights to Save His Company After a 99% Crash
Benzinga · 5d ago
Weekly Report: what happened at NAKA last week (0824-0828)?
Weekly Report · 08/31 09:53
Weekly Report: what happened at NAKA last week (0817-0821)?
Weekly Report · 08/24 09:53
Nakamoto Inc’s CEO Just Made a Bold Insider Move That Could Turn Heads on Wall Street
TipRanks · 08/22 02:07
Crypto Currents: Trump calls on Congress to pass Clarity Act
TipRanks · 08/21 14:00
Top Executive Quietly Boosts Stake in Nakamoto Inc., Hinting at Big Moves Ahead
TipRanks · 08/21 02:05
Analysts Offer Insights on NA Companies: Waterbridge Infrastructure LLC Class A (WBI), Nakamoto Inc (NAKA) and Ethos Technologies Inc. Class A (LIFE)
TipRanks · 08/20 12:10
Corporate crypto crunch: 80% of public treasuries submerged
Seeking Alpha · 08/19 15:36
Nakamoto price target lowered to $9 from $20 at B. Riley
TipRanks · 08/17 13:11
Weekly Report: what happened at NAKA last week (0810-0814)?
Weekly Report · 08/17 09:54
Nakamoto reports Q2 EPS ($6.56)
TipRanks · 08/17 07:46
Analysts Offer Insights on NA Companies: Nakamoto Inc (NAKA) and Aardvark Therapeutics, Inc. (AARD)
TipRanks · 08/14 16:40
Nakamoto EPS of -$6.56, revenue of $35.87M beats by $26.45M
Seeking Alpha · 08/13 12:39
Accelerant Holdings (ARX) Tops Q2 Earnings and Revenue Estimates
NASDAQ · 08/13 12:35
*Nakamoto 2Q Rev $35.9M >NAKA
Dow Jones · 08/13 12:31
More
Webull provides a variety of real-time NAKAW stock news. You can receive the latest news about Nakamoto Inc through multiple platforms. This information may help you make smarter investment decisions.
About NAKAW
Kindly MD, Inc. is a healthcare data company focused on holistic pain management and reducing the impact of the opioid epidemic. The Company offers direct health care to patients, integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a fee-for-service basis. The Company offers evaluation and management, including, but not limited to, chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. The Company also collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The Company captures all relevant data points to assist and appropriately treat each individual patient.